Anti-INO80 antibody
4
(1 Review)
|
(16 Publications)
Rabbit Polyclonal INO80 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 16 publications. Immunogen corresponding to Synthetic Peptide within Human INO80 aa 1500 to C-terminus.
View Alternative Names
INO80A, INOC1, KIAA1259, INO80, Chromatin-remodeling ATPase INO80, hINO80, DNA helicase-related INO80 complex homolog 1, DNA helicase-related protein INO80, INO80 complex subunit A
- IP
Unknown
Immunoprecipitation - Anti-INO80 antibody (AB118787)
Detection of INO80 in Immunoprecipitates of Hela whole cell lysates (1 mg for IP, 20% of IP loaded) using ab118787 at 6 µg/mg lysate for IP (Lane 1) and at 1 µg/ml for subsequent Western blot detection. Lane 2 represents control IgG IP.
Detection : Chemiluminescence with an exposure time of 30 seconds.
All lanes:
Immunoprecipitation - Anti-INO80 antibody (ab118787)
Predicted band size: 176 kDa
false
- WB
Unknown
Western blot - Anti-INO80 antibody (AB118787)
All lanes:
Western blot - Anti-INO80 antibody (ab118787) at 0.1 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
HeLa whole cell lysate at 15 µg
Lane 3:
293T whole cell lysate at 50 µg
Lane 4:
Jurkat whole cell lysate at 50 µg
Predicted band size: 176 kDa
true
Exposure time: 30s
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The INO80 complex affects gene expression and DNA stability. The INO80 protein forms part of the larger INO80 chromatin remodeling complex which includes several other subunits. This complex helps regulate chromatin structure by repositioning nucleosomes and altering histone-DNA interactions. These actions support the maintenance of genome integrity and facilitate accurate gene expression by modifying the accessibility of DNA to transcription factors and the transcription machinery.
Pathways
The INO80 complex impacts critical pathways for DNA repair and replication such as the homologous recombination repair pathway and the cell cycle checkpoint pathways. The homologous recombination repair is essential for fixing double-strand breaks in DNA and involves related proteins such as RAD51. Moreover INO80 interacts with proteins like RuvB-like helicases which assist in the structural rearrangement of chromatin during these processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (16)
Recent publications for all applications. Explore the full list and refine your search
Glia 73:1307-1323 PubMed40017313
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 84:2525-2541.e12 PubMed38906142
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature 627:671-679 PubMed38448585
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:13235 PubMed37580530
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 37:110138 PubMed34936865
2021
Applications
Unspecified application
Species
Unspecified reactive species
Genome biology 22:294 PubMed34663418
2021
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 39:e105098 PubMed32960481
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 11:4534 PubMed32913330
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cells 9: PubMed32708675
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Biochemical journal 476:3053-3066 PubMed31657441
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com